Clinical Experience with Dipaxin and with the Combined Use of Prothrombopenic Agents
The experience with a new prothrombopenic agent, Dipaxin, is presented. With a 30 mg. dose a prothrombin complex concentration under 30 per cent is reached in 41 hours or less. When associated with 1500 mg. of Tromexan the latent period is reduced to 24 hours. The prothrombopenic action of Dipaxin is readily counteracted with vitamin K1 administered either orally or intravenously.
- © 1954 American Heart Association, Inc.